Rana R. McKay, MD | Authors


Recent Milestones in the Field of RCC

January 27, 2018

Rana R. McKay, MD, medical oncologist, assistant professor, Moores Cancer Center at the University of California, San Diego, discusses advances in the treatment of metastatic renal cell carcinoma (RCC).

The Impact of Angiotensin System Inhibitors on Outcomes in Patients with mRCC

January 31, 2014

Rana R. McKay, MD, a clinical oncology fellow at Dana-Farber Cancer Institute, Boston, Massachusetts, discusses a trial that analyzed overall survival in patients with metastatic renal cell carcinoma who used angiotensin system inhibitors.